
Retina research update
Characteristics of patients with complete VA recovery after vitrectomy for macula-off retinal detachmentKonstantinidis L et alEye (Lond). 2021 Oct;35(10):2834-2839

Characteristics of patients with complete VA recovery after vitrectomy for macula-off retinal detachmentKonstantinidis L et alEye (Lond). 2021 Oct;35(10):2834-2839

Over the years I've found that writing about the informal aspects of being a part- or full-time 'Blindy' is an odd way to pass the time. It often presents 'challenges' (what we used to call 'problems').

Uveitis is a fascinating world but can be intimidating for the uninitiated. Outside anterior uveitis and scleritis, many uveitis diseases are uncommon and this is reflected by the limited number of uveitis subspecialists in ophthalmology. In agreement with the rarity of these diseases, few textbooks

No matter how talented individual leaders and managers are, a business’ ability to work as one team is key to your overall business success. This is especially true in this time of uncertainty and where many are working remotely. Now, more than ever, it’s critical you have connected and engaged team

Rather than bemoan the cancellation of in-person meetings due to the Covid-19 pandemic, the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) opted to fully embrace the possibilities of the virtual format this year. Although there is no substitute for face-to-face interaction, the vir

At the 2021 glaucoma-focused Ocular Therapeutics Evening (OTE), Auckland-based ophthalmologists Drs Hussain Patel and Divya Perumal highlighted New Zealand’s dearth of preservative-free eye drop options for their glaucoma patients.

Ciclosporin (Ikervis) has been listed on the Pharmaceutical Benefits Scheme (PBS) in Australia, saving around 7,500 severe keratitis patients with dry eye disease (DED) an estimated A$900 each per year, said Greg Hunt, Minister for Health and Aged Care.

With a large (and growing) number of New Zealanders undergoing cancer therapy, eyecare professionals should be cognisant of the ocular complications that can result from many of these treatments to ensure their timely and appropriate diagnosis and management. Although chemotherapy remains a mainstay

Patient harm due to diagnostic error of neuro-ophthalmologic conditionsStunkel L et al

Dr William (Bill) Taylor passed away on 5 September 2021 at the age of 83 after suffering from ill-health for a few years.

Gathering eye injury data since 2019, The International Globe and Adnexal Trauma Epidemiology Study (IGATES) is increasingly identifying national and demographic trends, plus some unexpected lockdown effects. To find out more, Drew Jones spoke to principal investigators Dr Rupesh Agrawal, from Tan T

The force behind many pivotal moments in ophthalmic nursing in New Zealand over the past 30 years, Sue Raynel spent her nursing career campaigning for change for better patient care. With retirement looming, Louise Wood took a look at just some of these achievements.